We encountered 3 cases of twin-twin transfusion syndrome (TTTS), in which preoperative ultrasonography revealed that the cord insertion sites of the twins were close. Two cases were successfully treated with fetoscopic laser photocoagulation (FLP); however, the third case could not be treated surgically because fetoscopy revealed that the cord insertions formed a V-shaped joint above the placenta and that all chorionic vessels of the placental surface were shared by the twins. No residual anastomoses were detected on placental examination in the 2 cases treated with FLP. Our experiences indicate that the feasibility of FLP could be evaluated using fetoscopy, not just ultrasonography, in cases of TTTS accompanied by proximate umbilical cord insertion.

1.
Murakoshi T, Ishii K, Nakata M, Sago H, Hayashi S, Takahashi Y, Murotsuki J, Matsushita M, Shinno T, Naruse H, Torii Y; Japan Fetoscopy Group: Validation of Quintero stage III sub-classification for twin-twin transfusion syndrome based on visibility of donor bladder: characteristic differences in pathophysiology and prognosis. Ultrasound Obstet Gynecol 2008;32:813-818.
2.
Senat MV, Deprest J, Boulvain M, Paupe A, Winer N, Ville Y: Endoscopic laser surgery versus serial amnioreduction for severe twin-to-twin transfusion syndrome. N Engl J Med 2004;351:136-144.
3.
Rossi AC, D'Addario V: Laser therapy and serial amnioreduction as treatment for twin-twin transfusion syndrome: a metaanalysis and review of literature. Am J Obstet Gynecol 2008;198:147-152.
4.
Yonetani N, Ishii K, Kawamura H, Mabuchi A, Hayashi S, Mitsuda N: Significance of velamentous cord insertion for twin-twin transfusion syndrome. Fetal Diagn Ther 2015, Epub ahead of print.
5.
Gandhi M, Papanna R, Moise K, Popek E, Johnson A, Moise KJ Jr: Treatment of twin-twin transfusion syndrome with proximate umbilical cord insertions. J Ultrasound Med 2011;30:1151-1155.
6.
Zhao DP, Peeters SH, Middeldorp JM, Klumper FJ, Oepkes D, Lopriore E: Laser surgery in twin-twin transfusion syndrome with proximate cord insertions. Placenta 2013;34:1159-1162.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.